{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"138.4","value":"7.8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"description":"Changes in Neutrophils between baseline and mean neutrophils values during treatment (measured after each dose)","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive oral deferasirox once daily for up to 6 months or until blood counts recover in the absence of disease progression or unacceptable toxicity.\n\ndeferasirox : Given orally\n\nlaboratory biomarker analysis : Correlative studies\n\nenzyme-linked immunosorbent assay : Correlative studies","id":"OG000","title":"Arm I"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Baseline, up to 6 months","title":"Changes in Mean Neutrophil Values (as Measured by Lab) for Arm 1 (Other Arms Were Used for Calibration Only)","type":"PRIMARY","unitOfMeasure":"10^9 Neutrophils per Liter"}